Corporate News

Grant of SAYE options

10 July 2017

Quantum Pharma Plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier is pleased to announce that on 7 July 2017 pursuant to the Quantum Pharma Plc Save-As-You-Earn Plan (SAYE), the Company has granted options, under which employees have been offered the opportunity to participate in the future growth of the Company via share option arrangements.

UK and Greek based employees were invited to subscribe for options over the Company's Ordinary Shares of 10 pence each ('Ordinary Shares') with an exercise price of 42.87 pence, a 20% discount to the average closing middle market price of the Company's Ordinary Shares on 9, 12 and 13 June 2017, the three trading days prior to the invitation to participate was made.  The options have a contract start date of 1 September 2017 and are exercisable between 1 September 2020 and 28 February 2021.

A total of 98 employees elected to participate, and pursuant to these elections a total of 981,519 options over Ordinary Shares have been issued, equating to approximately 0.58% of the current issued share capital.

Following the above SAYE grant and other recent lapses or grants of Long Term Incentive Plan options (LTIP) or earlier SAYE grants, there are outstanding options over 16,243,928 Ordinary Shares, representing approximately 9.61% of the current issued share capital, of which options over 15,610,828 Ordinary Shares are included in the calculation of the 10% limit under the LTIP and SAYE share plan rules.


For further information:

Quantum Pharma Plc  
Chris Rigg, Chief Executive Officer Tel: +44 (0) 1207 279 404
Gerard Murray, Chief Financial Officer  
N+1 Singer
(Nominated Advisor & Broker)
Sandy Fraser / Nick Owen / James White Tel: +44 (0) 20 7496 3000
Media enquiries:  
Sophie Cowles / Steph Watson Tel: +44 (0) 20 7466 5000


Notes to Editors

Quantum Pharma Plc is a service-led, niche pharmaceutical developer, manufacturer and supplier to the retail pharmacy, pharmaceutical wholesale and hospital markets. Quantum Pharma Plc operates through two divisions - Specials and Niche Pharmaceuticals - offering a portfolio of innovative and complementary products and services.

For further information, please visit


back to top

back to Corporate News


Quantum Pharmaceuticals
UL Medicines
Quantum Aseptics
PERN Consumer Products